News Conference News TCT 2017 Help for Clinicians Whose Patients Need to Switch P2Y12 Inhibitors Todd Neale October 30, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2017 Shelley Wood October 29, 2017
News Conference News TCT 2017 TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More Shelley Wood October 20, 2017
News Daily News Lower Limb Revascularizations Increasing in PAD Patients on Dialysis L.A. McKeown October 18, 2017
News Daily News Severe Aortic Stenosis Gets Its Own Appropriate Use Criteria Caitlin E. Cox October 18, 2017
News Daily News What Works, What Matters? Patient-Centered Endpoints Gain Traction in CV Clinical Trials Caitlin E. Cox October 13, 2017
News Daily News Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force Michael O'Riordan October 11, 2017
News Daily News Rivaroxaban Trial in Patients With Embolic Stroke of Undetermined Source Stopped Early Todd Neale October 09, 2017
News Daily News Same-Same but Different? Noninferiority Trials Need a Revamp, NEJM Review Argues Caitlin E. Cox October 06, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2017 Shelley Wood September 30, 2017
News Daily News FDA Grants HeartWare LVAD a Destination Therapy Indication Todd Neale September 28, 2017
News Conference News PCR London Valves 2017 TAVR Takeover? Experts Debate Timing of Surgery’s Ousting in Aortic Stenosis Shelley Wood September 24, 2017
News Daily News New Guidelines for Cardiogenic Shock Push for Regionalized Care, More Research Shelley Wood September 21, 2017
News Conference News VIVA 2017 Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD L.A. McKeown September 18, 2017
News Conference News VIVA 2017 ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA L.A. McKeown September 15, 2017
News Features Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen? Michael O'Riordan September 13, 2017
News Conference News VIVA 2017 Apixaban May Be Better Choice Than Rivaroxaban for DVT Patients L.A. McKeown September 11, 2017
News Opinion Editor's Corner ESC 2017 My Takeaways From ESC 2017: That Lovin’ Feeling? Barcelona Brings It Back Shelley Wood September 08, 2017
News Opinion Editor's Corner ESC 2017 ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On Shelley Wood August 18, 2017